The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Feb. 26, 2025 — Scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ...

Triple board-certified physician Dr. Lisa Koche, founder of Spectra Wellness Solutions, recently joined Gayle Guyardo, host ...

American Idol winner and Blue Springs native David Cook will be back in town this weekend to support a police officer who’s ...

Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor. This enzyme plays a vital role in the hexosamine ...

New research reveals that chemotherapy can lead to rapid and widespread changes in brain connectivity in breast cancer patients. Using functional MRI scans, scientists observed disruptions in the ...

The “Real Housewives of Beverly Hills” star recently revealed that her dad has planned her funeral as her melanoma has spread ...

Currently, complex and large-molecule drugs for hard-to-treat cancers and other diseases cannot be administered as a pill and easily absorbed into cells ... have to treat brain cancer or dementia." ...

and even some brain cells. The strategy was particularly successful for a class of complex, large-sized drugs known as bRo5 molecules, such as PROTACs, a type of targeted cancer therapy that ...

The study, published in Nature Cell Biology, highlights how the metabolic environment of tumors influences the function of T cells, which are critical immune cells responsible for eliminating cancer.

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...